PT - JOURNAL ARTICLE AU - Clark, Shaunna L. AU - Chan, Robin F. AU - Zhao, Min AU - Xie, Lin Y. AU - Penninx, Brenda W.J.H. AU - Aberg, Karolina A. AU - van den Oord, Edwin J.C.G. TI - Dual methylation and hydroxymethylation study in blood and brain identifies <em>BAIAP2</em> as a mediator of gene expression differences associated with alcohol use disorder AID - 10.1101/2020.09.16.20194639 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.16.20194639 4099 - http://medrxiv.org/content/early/2020/09/18/2020.09.16.20194639.short 4100 - http://medrxiv.org/content/early/2020/09/18/2020.09.16.20194639.full AB - Background Using a three-stage, multi-tissue design we sought to characterize methylation and hydroxymethylation changes in blood and brain associated with alcohol use disorder (AUD).Methods In the discovery stage, we used epigenomic deconvolution to perform cell-type specific methylome-wide association studies within subpopulations of granulocytes/T-cells/B-cells/monocytes in 1,132 blood samples. Blood findings were examined for overlap with AUD-related methylation and hydroxymethylation in 50 human post-mortem brain samples in the brain overlap stage. Follow-up analyses investigated if overlapping findings mediated AUD-associated transcription changes in the same brain samples in the final stage.Results Cell-type specific analyses in blood identified methylome-wide significant associations in monocytes and T-cells. One of the top genic findings is located in PLA2G4A, a gene required for monocyte chemotaxis. Alcohol inhibits monocyte chemotaxis, thereby contributing to alcohol-induced inflammation. The monocyte findings were significantly enriched for AUD-related methylation and hydroxymethylation in brain. Hydroxymethylation in BAIAP2 was found to mediate AUD-associated transcription in the same brain samples. BAIAP2 regulates dendritic spine density and is linked to cognitive deficits that are clinical features of advanced AUD.Conclusions As part of the most comprehensive methylation study of AUD to date, this work involved the first cell-type specific methylation study of AUD conducted in blood, identifying methylation sites that are involved in alcohol-induced inflammation. In this first study to consider the role of hydroxymethylation in AUD, we found evidence for a novel mechanism for AUD brain-related impairments. Our results suggest promising new avenues for AUD research.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Institutes of Health (R01MH099110 to E.J.C.G., and 1R01AA026057 to S.L.C.), the VCU CTSA (UL1TR002649 from the National Institutes of Health National Center for Advancing Translation Science and CCTR Endowment Fund of the Virginia Commonwealth University, and a NARSAD Young Investigator Grant from the Brain &amp; Behavior Research Foundation. The funding sources had no role in the study design, writing of the report or decision to submit the article for publication. The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (ZonMw, grant number 10-000-1002) and financial contributions by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Leiden University Medical Center, Leiden University, GGZ Rivierduinen, University Medical Center Groningen, University of Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Rob Giel Onderzoekscentrum). Tissues were received from the New South Wales Brain Tissue Resource Centre at the University of Sydney. Research reported in this publication was supported by the National Institute of Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number R28AA012725. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Texas A&amp;M University IRB waived ethical approval of the entire study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon request and approval from the authors.